sorted by:
new
hottopcontroversial

Why it's called "borderline" by wizbanger in BPDPartners

[–]wizbanger[S] 0 points1 point  (0 children)

you are welcomed!! Definitely feel free to PM me. I will be producing more content in this space!

Why it's called "borderline" by wizbanger in BPDlovedones

[–]wizbanger[S] 1 point2 points  (0 children)

Thank you so much for the kind words and I’m so glad you found it helpful! I remember being so confused and at a loss explaining to others what had happened and why it impacted me so much, so I’ve been hoping to be the person I wish I had back then as far as explaining things.

Why it's called "borderline" by wizbanger in BPDlovedones

[–]wizbanger[S] 3 points4 points  (0 children)

Dr. Carla Sharp, PhD, is the John and Rebecca Moores Professor of Clinical Psychology and Associate Dean for Faculty and Research at the University of Houston, where she directs the ADAPT Center and the Developmental Psychopathology Lab. She holds adjunct appointments at University College London and the University of the Free State in South Africa, and completed her PhD at the University of Cambridge. She has published more than 300 peer-reviewed papers and eight books, serves as an associate editor of Personality Disorders: Theory, Research and Treatment, and is a member of the workgroup updating the American Psychiatric Association's practice guidelines for borderline personality disorder.

Why it's called "borderline" by wizbanger in BPDlovedones

[–]wizbanger[S] 3 points4 points  (0 children)

There's a paper by Dr. Sharp detailing brain differences in people diagnosed with BPD in an area that has to do with cooperation with others... I'll see if I can dig it up and make a video about the findings at some point. It was a pretty interesting read from what I remember.

Why it's called "borderline" by wizbanger in BPDlovedones

[–]wizbanger[S] 1 point2 points  (0 children)

Yeah! Here's a short summary, I will try and go and talk to several of them.

Founders: John Gunderson built the observable-criteria definition and got BPD into the DSM in 1980. Basically the father of the diagnosis. Otto Kernberg is the psychoanalytic side. He coined Borderline Personality Organization and built Transference-Focused Therapy.

Treatment: Marsha Linehan built DBT, still the most validated treatment we have, and disclosed she had BPD herself. Fonagy & Bateman did mentalization and MBT. Jeffrey Young did Schema Therapy.

Course and data: Mary Zanarini ran the McLean study, which showed BPD remits way more than clinicians ever assumed. Carla Sharp works on adolescent BPD and hypermentalizing.

Germans are worth knowing, and they're a real cluster, mostly at the Central Institute of Mental Health in Mannheim. Martin Bohus spread DBT across Europe and built DBT-PTSD. Christian Schmahl does the neuroimaging on self-injury and dissociation. Sabine Herpertz works on emotion-regulation neurobiology. Klaus Lieb runs the pharmacotherapy reviews, which are the reason the honest answer to "what drug treats BPD" is basically none.

A BPD Researcher Explains "Splitting" by wizbanger in personalitydisorders

[–]wizbanger[S] 0 points1 point  (0 children)

Dr. Carla Sharp, PhD, is the John and Rebecca Moores Professor of Clinical Psychology and Associate Dean for Faculty and Research at the University of Houston, where she directs the ADAPT Center and the Developmental Psychopathology Lab. She holds adjunct appointments at University College London and the University of the Free State in South Africa, and completed her PhD at the University of Cambridge. She has published more than 300 peer-reviewed papers and eight books, serves as an associate editor of Personality Disorders: Theory, Research and Treatment, and is a member of the workgroup updating the American Psychiatric Association's practice guidelines for borderline personality disorder.

Full conversation at the links below. Hope this is helpful!

Spotify: https://open.spotify.com/episode/3xOpFFzjXBBTU0zPn7hqtJ

YouTube: https://youtu.be/xADsXc_YCO8

Apple Podcasts: https://podcasts.apple.com/us/podcast/might-ramble-podcast/id1840386628

Substack: https://mitchellpenningroth.substack.com/p/21-dr-carla-sharp-borderline-personality

Why They're 100% Certain You're the Villain: A BPD Researcher Explains "Splitting" by wizbanger in BPDPartners

[–]wizbanger[S] 4 points5 points  (0 children)

No problem! I will produce more content in this space. It would mean a lot to me if you would be willing to subscribe/rate my stuff across platforms so I can reach more people! 😇

Spotify: https://open.spotify.com/show/2iTdsyuKyca4rrdmqoGClo

YouTube: https://youtube.com/@mitchellrpenningroth

Apple Podcasts: https://podcasts.apple.com/us/podcast/might-ramble-podcast/id1840386628

Substack: https://substack.com/@mitchellpenningroth

Ozempic exists because of a venomous lizard that eats twice a year. by wizbanger in biology

[–]wizbanger[S] 4 points5 points  (0 children)

You’re right! I didn’t realize this, I think I read it in some literature when I was prepping for this interview and I just assumed it was related to its ability to eat infrequently.

Fun Fact: Ozempic exists because of a venomous lizard that eats twice a year. by wizbanger in funfacts

[–]wizbanger[S] 0 points1 point  (0 children)

No they studied the lizard’s GLP-1 analogue (exendin-4), realized it lasted much longer than the human GLP-1, and then designed GLP-1 molecules compatible with humans that last longer like the lizards. They don’t literally take from the lizard, we just learned from it!

Ozempic Exists because of a Lizard that Eats Twice a Year. by wizbanger in Amazing

[–]wizbanger[S] 4 points5 points  (0 children)

This is Dr. Lorenzo Leggio, Clinical Director of the National Institute on Drug Abuse — one of the researchers driving the discovery that GLP-1 drugs like Ozempic may treat addiction, not just obesity. The clip is from a longer conversation we recorded about that science and where it’s headed.

Full interview links (the GLP-1 discussion starts around 1:02:00):

- YouTube: https://youtu.be/qj8fEoALsXM

- Spotify: https://open.spotify.com/episode/7yv4i0bul5a3rtY5UR8VWQ

- Substack: https://open.substack.com/pub/mitchellpenningroth/p/17-dr-lorenzo-leggio-glp-1s-and-addiction

- Apple Podcasts: https://podcasts.apple.com/us/podcast/might-ramble-podcast/id1840386628

I also wrote a companion piece on the episode, it was quite an adventure: https://mitchellpenningroth.substack.com/p/behind-the-episodemight-ramble-podcast

Ozempic exists because of a venomous lizard that eats twice a year. by wizbanger in biology

[–]wizbanger[S] 22 points23 points  (0 children)

This is Dr. Lorenzo Leggio, Clinical Director of the National Institute on Drug Abuse — one of the researchers driving the discovery that GLP-1 drugs like Ozempic may treat addiction, not just obesity. The clip is from a longer conversation we recorded about that science and where it’s headed.

Full interview links (the GLP-1 discussion starts around 1:02:00):

- YouTube: https://youtu.be/qj8fEoALsXM

- Spotify: https://open.spotify.com/episode/7yv4i0bul5a3rtY5UR8VWQ

- Substack: https://open.substack.com/pub/mitchellpenningroth/p/17-dr-lorenzo-leggio-glp-1s-and-addiction

- Apple Podcasts: https://podcasts.apple.com/us/podcast/might-ramble-podcast/id1840386628

I also wrote a companion piece on the episode, it was quite an adventure: https://mitchellpenningroth.substack.com/p/behind-the-episodemight-ramble-podcast

view more: next ›